Trabectedin
YONDELIS (trabectedin) is a prescription intravenous alkylating drug used in cancer treatment. It's manufactured by Janssen Products, LP as a lyophilized powder for injection, with each vial containing 1 mg of trabectedin. Approved under NDA207953, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | YONDELIS (trabectedin) is a prescription intravenous alkylating drug used in cancer treatment. It's manufactured by Janssen Products, LP as a lyophilized powder for injection, with each vial containing 1 mg of trabectedin. Approved under NDA207953, it's administered by healthcare professionals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Trabectedin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Trabectedin — ANDA 207953 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207953"
}
]
|
| identifier | ANDA207953 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Trabectedin |
